AquaBounty Technologies (NASDAQ:AQB) Releases Earnings Results, Meets Expectations

AquaBounty Technologies (NASDAQ:AQB) posted its quarterly earnings data on Tuesday. The company reported ($0.88) earnings per share for the quarter, hitting the consensus estimate of ($0.88), RTT News reports. The business had revenue of $0.05 million during the quarter, compared to the consensus estimate of $0.10 million. AquaBounty Technologies had a negative net margin of 3,923.57% and a negative return on equity of 17.81%. During the same quarter in the prior year, the company posted ($1.60) earnings per share.

AquaBounty Technologies Stock Performance

Shares of AquaBounty Technologies stock traded down $0.04 on Friday, hitting $1.06. The company had a trading volume of 7,762 shares, compared to its average volume of 24,188. AquaBounty Technologies has a 52 week low of $0.81 and a 52 week high of $4.03. The company has a current ratio of 1.96, a quick ratio of 1.96 and a debt-to-equity ratio of 0.05. The business has a 50-day simple moving average of $1.14 and a 200-day simple moving average of $1.47.

AquaBounty Technologies Company Profile

AquaBounty Technologies, Inc, a biotechnology company, operates in the aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It also operates salmon farms using proprietary technology. In addition, the company offers AquAdvantage Salmon, a genetically engineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts.